Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Paul Engstrom

Email
Center AffiliationsCancer Prevention and Control

Publications (136) (print view)

no pagination
Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology. 1999 Dec;75(3):406-12.
Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer. 1999 Dec;81(7):1222-7.
Liu SC, Sauter ER, Clapper ML, Feldman RS, Levin L, Chen SY, Yen TJ, Ross E, Engstrom PF, Klein-Szanto AJ. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):597-603.
Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E. Prostate-specific antigen production in the female breast: Association with progesterone. Cancer Epidemiology Biomarkers & Prevention. 1998 Apr;7(4):315-20.
Shoda Y, Mischel W, Miller SM, Diefenbach M, Daly MB, Engstrom PF. Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. Journal of Clinical Psychology in Medical Settings. 1998 Mar;5(1):3-17.
Witte RS, Ryan LM, Schutt AJ, Carbone PP, Engstrom PF. PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma. Investigational New Drugs. 1998 Jan;16(4):315-8.
Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF. Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clinical Cancer Research. 1997 Jan;3(1):25-30.
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997 Jan;76(4):494-501.
Benincasa TA, King ES, Rimer BK, Bloom HS, Balshem A, James J, Engstrom PF. Results of an office-based training program in clinical breast examination for primary care physicians. Journal of Cancer Education. 1996 Jan;11(1):25-31.
Love RR, Engstrom PF. Cancer prevention and control investigators: The need for high quality training programs. Cancer Epidemiology Biomarkers & Prevention. 1996 Feb;5(2):141-2.
Odwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. Journal of Clinical Investigation. 1996 Sep;98(5):1210-7.
Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):967-70.
Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Management of Adenocarcinoma of the Esophagus with Chemoradiation Alone or Chemoradiation Followed by Esophagectomy - Results of Sequential Nonrandomized Phase-Ii Studies. International Journal of Radiation Oncology Biology Physics. 1995 Jun 15;32(3):753-61.
Cohen AM, Kane MJ, Engstrom PF, Marks JH, Marks GJ, Haller DG, Schneider CJ, Laucius JF, Mastrangelo MJ. Dukes C2 Colon-Cancer - What Is Appropriate Follow-Up. Seminars in Oncology. 1995 Jun;22(3):R19-&.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Paclitaxel by 24- or 1-Hour Infusion in Combination with Carboplatin in Advanced Nonsmall Cell Lung-Cancer - the Fox Chase Cancer Center Experience. Seminars in Oncology. 1995 Aug;22(4):18-29.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG. Results of Combined-Modality Therapy for Patients with Anal Cancer (E7283) - an Eastern-Cooperative-Oncology-Group-Study. Cancer. 1995 Nov 15;76(10):1731-6.
Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, Odwyer PJ. Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas. Investigational New Drugs. 1995 Jan;13(4):347-54.
Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF, Clapper ML. Glutathione-S-Transferase Activity and Glutathione-S- Transferase Mu-Expression in Subjects with Risk for Colorectal- Cancer. Cancer Research. 1995 Jul;55(13):2789-93.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Paul Engstrom Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Monday, November 04, 2019